Antiphospholipid syndrome and retinal vein occlusion in adults

East Mediterr Health J. 2004 Jul-Sep;10(4-5):627-32.

Abstract

Antiphospholipid antibodies may play and important role in the pathogenesis of retinal vascular occlusions; investigated the prevalence among 33 patients with retinal vein and artery occlusions and 80 controls. Prevalence was 33% and 5% respectively. Ophthalmic examination and fluorescein angiography showed that occlusions were due to ischaemic events. The 11 patients were diagnosed with antiphospholipid syndrome: 9 patients were treated successfully with laser photocoagulation and anticoagulant and anti-aggregant therapy. Two patients with antiphospholipid antibodies associated with resistance to activated protein C had unfavourable outcomes. Our results suggest a correlation between antiphospholipid syndrome and retinal vein occlusions; we recommend a systematic search for antiphospholipid antibodies in occlusions of unexplained origin and laser photocoagulation treatment and long-term oral anticoagulant and anti-aggregant therapy.

MeSH terms

  • Administration, Oral
  • Adult
  • Aged
  • Antibodies, Antiphospholipid / blood
  • Anticoagulants / therapeutic use
  • Antiphospholipid Syndrome / complications*
  • Antiphospholipid Syndrome / diagnosis
  • Antiphospholipid Syndrome / epidemiology
  • Antiphospholipid Syndrome / therapy
  • Case-Control Studies
  • Chi-Square Distribution
  • Female
  • Fluorescein Angiography
  • Humans
  • Laser Coagulation
  • Male
  • Mass Screening
  • Middle Aged
  • Ophthalmoscopy
  • Prevalence
  • Retinal Vein Occlusion / diagnosis
  • Retinal Vein Occlusion / epidemiology
  • Retinal Vein Occlusion / etiology*
  • Retinal Vein Occlusion / therapy
  • Surveys and Questionnaires
  • Treatment Outcome
  • Tunisia / epidemiology

Substances

  • Antibodies, Antiphospholipid
  • Anticoagulants